Abstract:

Cervical cancer is one of the most common malignant tumors in women. The treatment methods mainly include surgery and radiotherapy. Chemotherapy is widely used in combination with surgery and radiotherapy and the treatment of advanced recurrent cervical cancer. Among them, early cervical cancer is often used surgical treatment via open or minimally invasive route. The results of the clinical trial of the Laparoscopic Approach to Cervical Cancer (LACC) published in 2018 first questioned the short-term and long-term therapeutic effects and oncological risks of minimally invasive surgery for early-stage cervical cancer. They believed that the disease-free survival rate and overall survival rate of minimally invasive surgery for cervical cancer were lower than those of open surgery, which caused the global gynecologists to rethink the surgical methods. Due to the lack of reliable clinical evidence, minimally invasive surgery is still the standard treatment for cervical cancer. After a dispute between "laparotomy" and "minimally invasive surgery", a number of clinical studies have proved that minimally invasive surgery has higher recurrence rate, mortality rate and lower survival rate than open surgery in radical hysterectomy. Therefore, to delete the minimally invasive surgery of radical hysterectomy in the latest clinical guidelines, recommend open surgery is the standard path of radical hysterectomy for early cervical cancer, and point out the new trends of surgical treatment for early cervical cancer for gynecologists.

Key words: Uterine cervical neoplasms, Hysterectomy, Laparoscopy, Pneumoperitoneum,artificial, Survival analysis